Patents by Inventor Karen Onley Bacot

Karen Onley Bacot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6682891
    Abstract: Through function complementation of E. coli auxotrophs, the ultimate and pentultimate enzymes of the spinach riboflavin biosynthetic pathway have been cloned, namely, lumazine synthase (LS) and riboflavin synthase (RS). This invention relates to the isolation of nucleic acid fragments from plants or fungi that encode LS protein. The invention also relates to the isolation of nucleic acid fragments from plants or fungi that encode RS protein. In addition, the invention also relates to the construction of chimeric genes encoding all of a portion of LS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant LS in a transformed host cell. Furthermore, the invention also relates to the construction of chimeric genes encoding all of a portion of RS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant or fungal RS in a transformed host cell.
    Type: Grant
    Filed: June 5, 2001
    Date of Patent: January 27, 2004
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Paul Veikko Viitanen, Douglas Brian Jordan, Karen Onley Bacot
  • Publication number: 20020127670
    Abstract: Through function complementation of E. coli auxotrophs, the ultimate and pentultimate enzymes of the spinach riboflavin biosynthetic pathway have been cloned, namely, lumazine synthase (LS) and riboflavin synthase (RS). This invention relates to the isolation of nucleic acid fragments from plants or fungi that encode LS protein. The invention also relates to the isolation of nucleic acid fragments from plants or fungi that encode RS protein. In addition, the invention also relates to the construction of chimeric genes encoding all of a portion of LS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant LS in a transformed host cell. Furthermore, the invention also relates to the construction of chimeric genes encoding all of a portion of RS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant or fungal RS in a transformed host cell.
    Type: Application
    Filed: June 5, 2001
    Publication date: September 12, 2002
    Inventors: Paul Veikko Viitanen, Douglas Brian Jordan, Karen Onley Bacot
  • Publication number: 20020052023
    Abstract: Through function complementation of E. coli auxotrophs, the ultimate and pentultimate enzymes of the spinach riboflavin biosynthetic pathway have been cloned, namely, lumazine synthase (LS) and riboflavin synthase (RS). This invention relates to the isolation of nucleic acid fragments from plants or fungi that encode LS protein. The invention also relates to the isolation of nucleic acid fragments from plants or fungi that encode RS protein. In addition, the invention also relates to the construction of chimeric genes encoding all of a portion of LS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant LS in a transformed host cell. Furthermore, the invention also relates to the construction of chimeric genes encoding all of a portion of RS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant or fungal RS in a transformed host cell.
    Type: Application
    Filed: May 31, 2001
    Publication date: May 2, 2002
    Inventors: Paul Veikko Viitanen, Douglas Brian Jordon, Karen Onley Bacot
  • Patent number: 6350597
    Abstract: Through function complementation of E. coli auxotrophs, the ultimate and pentultimate enzymes of the spinach riboflavin biosynthetic pathway have been cloned, namely, lumazine synthase (LS) and riboflavin synthase (RS). This invention relates to the isolation of nucleic acid fragments from plants or fungi that encode LS protein. The invention also relates to the isolation of nucleic acid fragments from plants or fungi that encode RS protein. In addition, the invention also relates to the construction of chimeric genes encoding all of a portion of LS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant LS in a transformed host cell. Furthermore, the invention also relates to the construction of chimeric genes encoding all of a portion of RS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant or fungal RS in a transformed host cell.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: February 26, 2002
    Assignee: E. I. du Pont de Nemours & Company
    Inventors: Paul Veikko Viitanen, Douglas Brian Jordan, Karen Onley Bacot
  • Patent number: 6146866
    Abstract: Through function complementation of E. coli auxotrophs, the ultimate and pentultimate enzymes of the spinach riboflavin biosynthetic pathway have been cloned, namely, lumazine synthase (LS) and riboflavin synthase (RS). This invention relates to the isolation of nucleic acid fragments from plants or fungi that encode LS protein. The invention also relates to the isolation of nucleic acid fragments from plants or fungi that encode RS protein. In addition, the invention also relates to the construction of chimeric genes encoding all of a portion of LS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant LS in a transformed host cell. Furthermore, the invention also relates to the construction of chimeric genes encoding all of a portion of RS, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of plant or fingal RS in a transformed host cell.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: November 14, 2000
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Paul Veikko Viitanen, Douglas Brian Jordan, Karen Onley Bacot
  • Patent number: 6074830
    Abstract: Through functional complementation of an Escherichia coli auxotroph, 3,4-dihydroxy-2-butanone 4-phosphate synthase (DS), an indispensable enzyme of the riboflavin biosynthetic pathway of the rice blast fungus Magnaporthe grisea, has been cloned. This invention relates to the isolation of the nucleic acid fragment that encodes the fungal DS protein. In addition, the invention also relates to the construction of chimeric genes encoding all or a portion of the Magnaporthe grisea DS protein, in sense or antisense orientation, wherein the expression of the chimeric gene results in production of altered levels of Magnaporthe grisea DS in a transformed host cell. Finally, the invention also relates the use of the Magnaporthe grisea DS protein as a tool for identifying chemical agents that could be useful as fungicides, antibiotics, or herbicides.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: June 13, 2000
    Assignee: E. I. du Pont de Nemours & Company
    Inventors: Karen Onley Bacot, Douglas Brian Jordan, Paul Veikko Viitanen